Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

Clinical trial NCT00062647 · COMPLETED

Trial details

NCT number: NCT00062647
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-Positive Bacterial Infections

Start date: 2003-08-01
Primary completion: 2006-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.